Post Vaccination Evaluation of Anti-HBsAg Antibody Titers among Haemodialysis Patients

Principal Investigator(s):  View help for Principal Investigator(s) Ramahrishna Devaki

Version:  View help for Version V1

Name File Type Size Last Modified
ajmr-4-2-4 application/pdf 100.5 KB 08/01/2016 03:12:AM

Project Citation: 

Devaki, R. (2016). Post Vaccination Evaluation of Anti-HBsAg Antibody Titers among Haemodialysis Patients [Data set]. Inter-university Consortium for Political and Social Research [distributor]. https://doi.org/10.3886/E83534V1

Project Description

Summary:  View help for Summary Hepatitis B virus (HBV) is the second most common viral infection which poses threat of infection among health care workers and those individuals treated for various debilitated conditions in hospital settings. Patients undergoing haemodialysis are at a greater risk of acquiring HBV infection. Although HBV vaccination has been in use for almost three decades, it is not completely certain about its efficacy in long-term protection. Few studies in the past have emphasized the need for evaluation of anti-HBsAg antibody titers among high risk groups that include patients undergoing haemodialysis. Studies in the past have also noted that few vaccinated group do not respond to HBV vaccine and that few other group of vaccinated individuals develop inadequate antibody titers. The present study evaluated the antibody titers among haemodialysis patients and health care workers.

Scope of Project

Subject Terms:  View help for Subject Terms Haemodialysis


Related Publications

Request Information

This material is sensitive in nature and is available as restricted data through ICPSR. Users are required to apply for access, will be required to pay a fee, and will experience a wait time before access is given. The material will be distributed exactly as it arrived from the data depositor. ICPSR does not check or process the material.

Published Versions

V1 [2016-08-19]

Export Metadata

Dublin Core

DDI 2.5

Report a Problem

Found a serious problem with the data, such as disclosure risk or copyrighted content? Let us know.

This material is distributed exactly as it arrived from the data depositor. ICPSR has not checked or processed this material. Users should consult the investigator(s) if further information is desired.